Inactive Instrument

Vivimed Labs Ltd Share Price NSE India S.E.

Equities

INE526G01013

Pharmaceuticals

End-of-day quote NSE India S.E.
- INR - Intraday chart for Vivimed Labs Ltd

Financials

Sales 2022 2.39B 28.62M 2.28B Sales 2023 1.88B 22.56M 1.8B Capitalization 547M 6.57M 523M
Net income 2022 -677M -8.12M -647M Net income 2023 -3.28B -39.41M -3.14B EV / Sales 2022 1.98 x
Net Debt 2022 3.52B 42.19M 3.36B Net Debt 2023 3.77B 45.26M 3.61B EV / Sales 2023 2.3 x
P/E ratio 2022
-1.78 x
P/E ratio 2023
-0.17 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 74.35%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 62 08/11/89
Compliance Officer - -
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Chief Executive Officer 62 08/11/89
Director/Board Member 55 22/01/08
Director/Board Member 76 08/11/89
More insiders
Vivimed Labs Limited is an India-based company, which is primarily engaged in the business of active pharmaceuticals ingredients, contract development and manufacturing operations finished dosage formulation, specialty chemicals and retail branded formulation manufacturing. The Company has two segments: Speciality Chemicals Business and Pharma Business. It supplies niche molecules and formulations for healthcare, pharmaceuticals and specialty chemical consumers in nearly 50 countries. Its active ingredients are used in home and personal care products, such as hair, skin, oral care and anti-microbial preservatives. It also offers industrial care products, such as photo chromic dyes and imaging chemicals. Its presence in active pharmaceutical ingredients, finished dosage formulation (FDF) and retail branded formulation manufacturing, caters to the inner health of people. Within the FDF business, it provides contract manufacturing services and the manufacture of branded formulations.
More about the company